Journey Medical (DERM) Change in Receivables (2020 - 2026)
Journey Medical's (DERM) quarterly Change in Receivables came in at -$4.8 million in Q1 2026, down 159.59% YoY from $8.0 million in Q1 2025, and down 140.49% on a QoQ basis from $11.8 million in Q4 2025.
Journey Medical (DERM) Change in Receivables (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Change in Receivables data on file, last reported at -$4.8 million in Q1 2026.
- Quarterly Change in Receivables fell 159.59% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (down 26.2% YoY) and the FY2025 annual result came in at $19.3 million, up 532.2% from the prior year.
- Change in Receivables fell to -$4.8 million in Q1 2026, from $11.8 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $11.8 million in Q4 2025 to a low of -$10.4 million in Q2 2023.
- A 5-year average of $172588.2 and a median of -$83000.0 in 2022 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 14170.59% in 2023, down 10538.55% in 2023.
- Tracing DERM's Change in Receivables over 5 years: stood at -$51000.0 in 2022, then surged by 14170.59% to $7.2 million in 2023, then sank by 110.41% to -$747000.0 in 2024, then surged by 1674.16% to $11.8 million in 2025, then sank by 140.49% to -$4.8 million in 2026.
- The last three Change in Receivables figures came in at -$4.8 million (Q1 2026), $11.8 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | 11.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.24 Mn |
| Jun 30, 2026 | 11.24 Mn |
| Mar 31, 2026 | -4.76 Mn |
| Mar 31, 2026 | -4.76 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Mar 31, 2025 | 7.99 Mn |
| Mar 31, 2025 | 7.99 Mn |
| Dec 31, 2024 | -747,000.00 |
| Dec 31, 2024 | -747,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | -5.42 Mn |
| Mar 31, 2024 | -5.42 Mn |